| 2024 | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 107,0 M € | -2.6% | 109,8 M € | +68.8% | 65,1 M € | +75.6% | 37,0 M € | +6.7% | 34,7 M € | +33.1% | 26,1 M € | +2.6% | 25,4 M € | -30.8% | 36,8 M € | +42.6% | 25,8 M € | -7.3% | 27,8 M € | -3.6% | 28,8 M € | +6.6% | 27,0 M € | -7.2% | 29,2 M € | +11.8% | 26,1 M € | -5.4% | 27,6 M € | |
| EBITDA | 10,1 M € | -23.8% | 13,2 M € | +60.9% | 8,2 M € | +507.9% | -2,0 M € | -150.8% | 4,0 M € | +3.5% | 3,8 M € | +3.0% | 3,7 M € | -21.4% | 4,7 M € | +49.6% | 3,2 M € | +23.4% | 2,6 M € | -18.4% | 3,1 M € | -8.5% | 3,4 M € | +10.2% | 3,1 M € | +16.0% | 2,7 M € | -21.5% | 3,4 M € | |
| Operating profit | 5,9 M € | -40.5% | 10,0 M € | +82.3% | 5,5 M € | +265.3% | -3,3 M € | -396.0% | 1,1 M € | -69.2% | 3,6 M € | -8.0% | 3,9 M € | -8.2% | 4,3 M € | +66.5% | 2,6 M € | +27.6% | 2,0 M € | -7.4% | 2,2 M € | -20.3% | 2,7 M € | +15.1% | 2,4 M € | +44.8% | 1,6 M € | -41.4% | 2,8 M € | |
| Profit/loss | 34,1 M € | +1055.1% | 3,0 M € | +78.4% | 1,7 M € | +127.9% | -5,9 M € | -113.1% | 45,1 M € | +2003.1% | 2,1 M € | -6.0% | 2,3 M € | +33.5% | 1,7 M € | +81.3% | 943,0 k € | +131.8% | -3,0 M € | -224.3% | 2,4 M € | +145.5% | -5,2 M € | -1076.6% | 536,4 k € | +90.0% | 282,3 k € | -73.5% | 1,1 M € | |
| Equity | 90,1 M € | +60.9% | 56,0 M € | +12.5% | 49,8 M € | +3.4% | 48,1 M € | -11.0% | 54,0 M € | +632.2% | 7,4 M € | +41.0% | 5,2 M € | +77.3% | 3,0 M € | +137.5% | 1,2 M € | +163.1% | -2,0 M € | -297.9% | 995,0 k € | +62.5% | 612,4 k € | -79.1% | 2,9 M € | +22.4% | 2,4 M € | +13.4% | 2,1 M € | |
| Total assets | 281,5 M € | +125.7% | 124,7 M € | +9.0% | 114,4 M € | +15.4% | 99,1 M € | -5.5% | 104,9 M € | +285.5% | 27,2 M € | +14.4% | 23,8 M € | +4.7% | 22,7 M € | -9.8% | 25,2 M € | -23.8% | 33,1 M € | -4.5% | 34,6 M € | -1.1% | 35,0 M € | +5.0% | 33,3 M € | -5.1% | 35,1 M € | +27.1% | 27,6 M € | |
| Cash | 1,0 M € | -93.9% | 16,7 M € | +13.5% | 14,7 M € | +85477.0% | 17,2 k € | -99.7% | 6,1 M € | +25509.6% | 24,0 k € | -86.0% | 171,2 k € | -81.9% | 943,7 k € | +373.5% | 199,3 k € | -46.9% | 374,9 k € | -55.5% | 843,3 k € | -27.6% | 1,2 M € | -55.7% | 2,6 M € | +398.0% | 527,8 k € | +5.6% | 500,0 k € | |
| Debts | 183,9 M € | +204.0% | 60,5 M € | +4.8% | 57,7 M € | +30.4% | 44,3 M € | -2.6% | 45,4 M € | +203.3% | 15,0 M € | +7.4% | 13,9 M € | -11.5% | 15,8 M € | -23.8% | 20,7 M € | -34.5% | 31,6 M € | +4.1% | 30,3 M € | -2.0% | 30,9 M € | +11.7% | 27,7 M € | -7.3% | 29,9 M € | +29.2% | 23,1 M € | |
| Staff | 217,7 | 184,9 | 130,3 | 112,3 | 107,4 | 99,7 | 94,6 | 90,2 | 92,1 | 96 | 104,4 | 103,8 | 106,9 | 103 | 94,5 | |||||||||||||||
Public limited company · Mechelen · incorporated on 07/02/1977 · 217,7 ETP
Public limited company profitable and well capitalised. Cash position declining (-93.9%).
Solid counterparty for a standard engagement.
DUOMED BELGIUM is a Public limited company incorporated in 1977. Its main activity is: Commerce de gros de produits pharmaceutiques. Its registered office is in Mechelen. It employs on average 217,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette